Confident Investing Starts With TipRanks Premium

Go Ultimate 55% OFF

SDZXF Stock Latest News

Company AnnouncementsSandoz Lifts Margin Guidance as Biosimilars Drive Q3 Growth4d ago

The FlySandoz price target raised to CHF 60 from CHF 55 at Morgan Stanley3w ago
Company AnnouncementsSandoz boosts European biosimilar capacity with new Slovenian plant1M ago
The FlymAbxience, Sandoz sign collaboration agreement for biosimilar access1M ago
Company AnnouncementsSandoz joins mAbxience to develop emicizumab biosimilar and expand haemophilia pipeline1M ago

Sandoz Wins Canadian Approval for Generic Semaglutide, Targeting Growing GLP-1 Market

Company AnnouncementsSandoz Wins Canadian Approval for Generic Semaglutide, Targeting Growing GLP-1 Market1M ago

The FlySandoz price target raised to CHF 72 from CHF 66 at Berenberg1M ago

Company AnnouncementsSandoz invests USD 300 million in new Slovenian biosimilar facility to boost capacity1M ago

Company AnnouncementsSandoz Unveils Bio100 Plan to Drive Golden Decade of Biosimilars1M ago
The FlySandoz initiated with a Buy at Erste Group2M ago
Company AnnouncementsSandoz expands biosimilar pipeline with major Henlius collaboration2M ago
The FlySandoz price target raised to CHF 80 from CHF 75 at JPMorgan2M ago

Sandoz H1 2026 profits surge as biosimilars drive growth and strategy

Company AnnouncementsSandoz H1 2026 profits surge as biosimilars drive growth and strategy2M ago

The FlySandoz takes steps to resolve U.S. generic medicine pricing litigation3M ago

Company AnnouncementsSandoz seals major U.S. settlements in generic drug antitrust saga3M ago

The FlySandoz confirms Brazil regulatory approval for new semaglutide treatment option3M ago
Company AnnouncementsSandoz wins Brazilian approval for new semaglutide diabetes treatment3M ago
Company AnnouncementsSandoz Reshapes Leadership to Seize Generics Growth Wave3M ago
Company AnnouncementsSandoz to Join Swiss Market Index in Milestone for Post-Listing Growth3M ago

Sandoz announces U.S. FDA accepted for review two ANDAs for tirzepatide

The FlySandoz announces U.S. FDA accepted for review two ANDAs for tirzepatide4M ago

Company AnnouncementsSandoz maps biosimilars ‘golden decade’ with capital markets day and Slovenia hub visit4M ago

Company AnnouncementsSandoz opens flagship biosimilar R&D hub in Slovenia to anchor $1.1bn expansion4M ago